-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
(Health Times reporter Wei Wei special correspondent Wang Guangchao/ Wen Liu Bing/Figure)
. Recently, the reporter learned from Fudan University affiliated oncology hospital urology surgery was informed: 16 years in the establishment of the department, the leader of the department, Fudan University affiliated oncology hospital vice president, Fudan University Prostate Cancer Research Center Director Professor Ye Dingwei personal master knife completed the amount of prostate cancer treatment surgery exceeded 3000 cases, the team prostate cancer treatment surgery volume exceeded 4000 cases. The treatment volume of the center for several years in Shanghai area urinary and male reproductive system tumor diagnosis and treatment of the first, the overall surgical volume ranked among the highest in China, the efficacy of patient treatment reached the international advanced level.
Professor Ye Dingwei and his team in China for the earliest multidisciplinary collaboration model (MDT) for the diagnosis and treatment of urinary and male reproductive system tumors, and he led the urology has become well-known at home and abroad urinary and male reproductive system tumor prevention, diagnosis, treatment and rehabilitation of the whole management center. Many original treatment measures were created, perfected, matured and extended to the whole country.
in recent years, the urology department of Fudan University Affiliated Oncology Hospital has taken the lead in using Internet technology and artificial intelligence technology to improve the construction of "two platforms" - the first full-time management online platform covering urinary and male reproductive system tumor patients in China, the first cross-regional urinary tumor MDT online consultation platform. At the same time, with the advantage of "two platforms" to promote high-quality medical resources and technology sinking, so that the advanced diagnosis and treatment concepts and technology will serve a wider range of domestic urinary tumor patients.
in addition to clinical treatment, since 2017, Ye Dingwei rate team in china to take the lead in the first time to start accurate screening for prostate cancer. The screening team entered seven communities in Shanghai, directly promoted the knowledge of prostate cancer prevention and treatment to the general public, and carried out prostate cancer screening for high-risk groups, a move that has been praised by the general population and established a feasible model for prostate cancer screening in China.
Ye Dingwei said that 4000 cases of prostate cancer treatment is only a small goal, innovation, progress is always on the road. Therefore, as the chief expert of the urological tumor MDT team, he also presided over a remote MDT consultation with Zhongshan Hospital affiliated with Dalian Medical University, and trained the students of the short course for prostate cancer "into the forefront".
.